Literature DB >> 1383853

Indications for surgery and prognosis in patients with cerebral cavernous angiomas.

H Bertalanffy1, G Kühn, R Scheremet, W Seeger.   

Abstract

Seventy-three cerebral cavernous angiomas were removed microsurgically from a series of 71 patients between August, 1983 and December, 1989. This retrospective investigation assessed the current indications for surgery and determined the prognosis for patients with cerebral cavernous angioma. There were 38 males and 33 females with a mean age of 37 years. Analysis included clinical presentation and history, neuroradiological findings, indications for surgery, and postoperative course. After an average follow-up period of 15 months, 35 patients were symptom-free, 16 had improved preoperative complaints, six were unchanged, and eight had deteriorated. Microsurgical extirpation of the malformation is indicated in all symptomatic patients where neuroimaging demonstrates the presence of a readily accessible cerebral cavernoma. Surgery is recommended in cases with deep-seated lesions causing massive hemorrhage, repetitive minor bleeding, or significant long-standing and progressive neurological disabilities. Clinically silent cavernomas located in eloquent regions of the brain contraindicate surgery, but should be closely monitored. Patients presenting with convulsions or neurological deficits caused by easily accessible cavernomas of the hemispheres have the best prognosis and a negligible risk for surgical complications. Those with deep-seated lesions of eloquent regions of the brain that have bled or caused sustained neurological disorders face the highest risk for morbidity owing to the surgical intervention, requiring careful preoperative evaluation.

Entities:  

Mesh:

Year:  1992        PMID: 1383853     DOI: 10.2176/nmc.32.659

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  7 in total

1.  Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q.

Authors:  L Notelet; F Chapon; S Khoury; K Vahedi; J P Chodkiewicz; P Courtheoux; M T Iba-Zizen; E A Cabanis; B Lechevalier; E Tournier-Lasserve; J P Houtteville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.

Authors:  M Fuetsch; F El Majdoub; M Hoevels; R P Müller; V Sturm; M Maarouf
Journal:  Strahlenther Onkol       Date:  2012-04       Impact factor: 3.621

3.  Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.

Authors:  Souvik Kar; Kiran Kumar Bali; Arpita Baisantry; Robert Geffers; Amir Samii; Helmut Bertalanffy
Journal:  J Mol Neurosci       Date:  2017-02-08       Impact factor: 3.444

Review 4.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 5.  PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Authors:  Souvik Kar; Amir Samii; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2014-11-19       Impact factor: 3.042

6.  Cavernous angiomas of the spinal cord clinical presentation, surgical strategy, and postoperative results.

Authors:  U Spetzger; J M Gilsbach; H Bertalanffy
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Stand-alone 3D-ultrasound navigation after failure of conventional image guidance for deep-seated lesions.

Authors:  Dorothea Miller; Ludwig Benes; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.